Ying Cheng

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0002-8940-8445

发表论文 111 篇 · 总被引 2969 次 · h-index 21

代表论文

• OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01 (2024 · Journal of Thoracic Oncology · 被引 32)
• Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer (2024 · Scientific Reports · 被引 21)
• IDeate-Lung02: A phase 3, randomized, open-label study of ifinatamab deruxtecan (I-DXd) vs treatment of physician’s choice (TPC) in relapsed small cell lung cancer (SCLC). (2024 · Journal of Clinical Oncology · 被引 14)
• Crosstalk between cancer-associated fibroblasts and non-neuroendocrine tumor cells in small cell lung cancer involves in glycolysis and antigen-presenting features (2024 · Molecular Medicine · 被引 13)
• A retrospective analysis of prognostic factors and treatment choices in small cell lung cancer with liver metastasis (2023 · Journal of Thoracic Disease · 被引 11)
• Advances in biomarkers for immunotherapy in small-cell lung cancer (2024 · Frontiers in Immunology · 被引 8)